News & Perspective

Sep 20, 2016

Sep 20, 2016

CDC ups Zika testing support; Florida reports more local cases

In other developments, without Zika funding federal officials have had to tap research money for cancer and other diseases.

Oct 18, 2011

Oct 18, 2011

Anthrax countermeasures better than in 2001, but work remains

(CIDRAP News) – If someone tried to kill Americans with Bacillus anthracis spores today, the nation would have a better medical tool chest for treating the sick and those potentially exposed than it had 10 years ago, when the anthrax letter attacks killed five people, but anthrax defenses are still a work in progress.

Aug 19, 2010

Aug 19, 2010

HHS sees greater federal role in building biodefense tools

(CIDRAP News) – Federal health officials, in releasing today a blueprint for overhauling the nation's civilian biodefense program, called for increased government partnerships with the private sector and a number of innovative steps to boost the development of medical countermeasures (MCMs) that have little or no commercial market.

Mar 07, 2006

Mar 07, 2006

HHS using Indonesian strain for second H5N1 flu vaccine

(CIDRAP News) – A second vaccine against human H5N1 influenza is being developed, US Health and Human Services (HHS) Secretary Mike Leavitt announced yesterday.

In a speech at an immunization conference, Leavitt announced that he has authorized the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) to start work on a second vaccine, according to an Associated Press (AP) report published yesterday.

Oct 20, 2005

Oct 20, 2005

US funds tularemia vaccine research, secure labs

(CIDRAP News) – The US government has issued about $60 million in contracts to spur development of a vaccine against tularemia, the National Institutes of Health (NIH) announced recently.

The National Institute of Allergy and Infectious Diseases (NIAID), a division of NIH, has issued two 5-year contracts for vaccine work, the agency said earlier this month. The agency also awarded $87 million in grants to build four biosafety level 3 (BSL-3) labs.

Nov 04, 2004

Nov 04, 2004

HHS to spend $877 million on new anthrax vaccine

Editor's note: A correction was made in this story Nov 9 to note that the existing licensed anthrax vaccine contains the natural rather than recombinant form of anthrax protective antigen.

(CIDRAP News) – Federal health officials today announced the award of an $877 million contract for 75 million doses of a new anthrax vaccine to protect the public and improve on the existing vaccine used by the military.

May 20, 2004

May 20, 2004

NIAID funds network to study eczema vaccinatum

(CIDRAP News) – An arm of the National Institutes of Health (NIH) has awarded more than $40 million worth of contracts for research to reduce the risk of eczema vaccinatum (EV), a rare but severe complication of smallpox vaccination.

Mar 12, 2004

Mar 12, 2004

FDA offers guidance on testing drugs for smallpox-shot side effects

(CIDRAP News) – The Food and Drug Administration (FDA) this week published guidelines for the development of drugs to treat the side effects of smallpox vaccination, an area in which the federal government is investing substantial research funds.

Dec 16, 2002

Dec 16, 2002

Half of second target group for smallpox shots may refuse them, officials estimate

(CIDRAP News) – Federal health officials project that about half of the estimated 10 million health and emergency response workers targeted for the second round of smallpox vaccinations will refuse the shots.

Pages

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»